美股異動|瑞銀盤前升超7.5% Q1淨利潤同比大增超七成 重申資本回報目標
瑞銀(UBS.US)美股盤前升超7.5%,報29.68美元。瑞銀第一季度營收為127.4億美元,同比增長46%,淨利潤17.6億美元,同比增長71%,遠超預期的5.98億美元。其中,淨利息收入19.4億美元,同比增加40%。瑞銀預計,將在5月31日之前完成與瑞士信貸的合法合併。瑞銀還表示,其目前的財務狀況將使其能夠執行其2024年的資本回報目標,包括計劃今年回購高達10億美元的股票,並在2024年將去年每股0.70美元的股息提高10%左右。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.